SingleStrand Biotech is a biotechnology company pioneering the development of synthetic single-stranded oligonucleotide (ODN) drugs that modulate the immune system and promote tissue regeneration. Our focus is on delivering next-generation therapies for chronic inflammatory diseases—starting with Crohn’s Disease—through innovative, precise, and long-lasting solutions.
Founded by leading researchers and supported by an experienced advisory board, SingleStrand Biotech merges academic excellence with entrepreneurial drive. With over two decades of experience in ODN research, our team has designed a platform that redefines how we approach immune modulation.
Company Details
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.singlestand.com
Single Strand Biotech Questions
Single Strand Biotech's website is http://www.singlestand.com
Single Strand Biotech's LinkedIn profile is https://www.linkedin.com/company/single-strabd-biotech
Single Strand Biotech's industry is
Biotechnology Research
Single Strand Biotech's top competitors are
Circa Therapeutics,
Vitropollen,
Odycell Nanotherapies,
Astronomer.
Single Strand Biotech's categories are Biotechnology Research
